Recruiting OBSERVATIONAL NCT07059923

Predicting Immunotherapy Response and Survival of Lung Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Lung)

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Updated 2 times since 2025 Last updated: Jul 1, 2025 Started: Jul 31, 2025 Primary completion: Aug 31, 2026 Completion: Aug 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07059923, this observational or N/A phase trial focuses on Lung Cancer (Diagnosis) and remains actively recruiting participants. Sponsored by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, it has been updated 2 times since 2025, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

2 versions recorded

Sep 2025 — Present [monthly]

Recruiting
Aug 2025 — Sep 2025 [monthly]

Recruiting

First recorded

Jul 2025

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Data source: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Wuhan, China